Dexmedetomidine (AFT) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: dexmedetomidine
Pack: Dexmedetomidine (AFT) 200 microgram/2 mL injection, 5 x 2 mL ampoules
Brand name
(ARTG)
: DEXMEDETOMIDINE-AFT dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection ampouleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Intensive Care Unit (ICU) Sedation: For sedation of initially intubated patients during treatment in an intensive care setting. The use of Dexmedetomidine-AFT by continuous infusion in these patients should not exceed 24 hours.,Procedural Sedation: For sedation of non-intubated patients prior to and/or during surgical and other procedures.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- A clear, colourless solution, free from visible particles and fibres
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 5 x 2 mL ampoules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient dexmedetomidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
